Islet Capsule Lowers Blood Sugar Levels in Diabetic Rats


By: Daniel Trecroci

Researchers at Kyoto University in Japan have discovered a technique in which a capsule containing pancreatic cells can be implanted into a patient with a minor case of diabetes.

In preliminary trials, pancreatic cells from a donor’s pancreas were implanted in the backs of five rats who suffered from diabetes. According to a recent issue of The Daily Yomiuri, the rats all demonstrated normal blood sugar levels for up to 80 days after taking the capsule.

The islets are enclosed in a 4.5-cubic-centimeter capsule, which could be implanted into a human being’s lower abdomen or thigh. According to Professor Kazutomo Inoue of the University Institute for Frontier Medical Science, the transplanted cells are expected to secrete insulin through holes just 200-billionths of a meter wide and not cause any side effects. The holes will not allow permeation of larger immunocytes, such as leukocytes and antibodies, and the recipient would not need immunosuppressants.

The research group has applied to Kyoto University’s bioethics committee to start clinical trials by the end of this year.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.